Free CME

Early identification of atypical motor patterns is crucial for timely intervention and optimizing developmental outcomes in infants. A simple yet effective method for assessing these patterns involves observing the baby during a 30-second, 4-position exam. This examination includes careful observation of the infant in the following positions:

* Supine: Note posture, spontaneous movements, and interaction with the environment.

* Horizontal Suspension: Observe head control, trunk extension, and limb movements against gravity.

* Pull to Sit: Assess head lag, trunk activation, and ability to assist with the movement.

* Prone: Evaluate head lifting, weight-bearing through the arms, and early mobility attempts. Gain valuable insights and download resources through this complimentary CME/CE course

Primary biliary cholangitis (PBC) causes chronic inflammation and progressive destruction of the bile ducts, resulting in cholestatic pruritus—a severe internal itch that scratching cannot relieve. Patients with PBC experience substantial impacts to their quality of life and face significant disparities in care across demographic, geographic, and socioeconomic factors. Adoption of standardized assessments and monitoring procedures can lead to earlier, more accurate diagnoses and personalized treatment plans across this patient population. Standard first-line treatment for this condition is ursodeoxycholic acid (UDCA) and, as of summer 2024, 2 novel peroxisome proliferator-activated receptor (PPAR) agonists have been approved for use in patients with inadequate response to UDCA.

These currently available treatments have demonstrated efficacy in improving liver function tests and reducing fibrosis progression, but do not target symptom management. Clinical investigations into novel therapies for managing PBC include additional PPAR agonists and fibroblast growth factor analogues, which have shown promise in improving liver function and reducing inflammation, as well as an ileal bile acid transport inhibitor, which has demonstrated efficacy in relieving cholestatic pruritus. In this CE activity, experts in the field detail the patient burden associated with PBC and the disparities in its care; evaluate processes and procedures that improve the assessment of patients with PBC; and distinguish current and emerging therapies for PBC symptom management regarding their targets and mechanisms of action.

Target Audience: Neurologists

Second-generation anti-vascular endothelial growth factor (VEGF) therapies with longer duration of action offer patients with neovascular age-related macular degeneration (nAMD) the potential for optimized visual and anatomical outcomes with extended intervals between doses. However, incorporating these newer therapies into individualized management protocols can be challenging. In this CE activity, Drs. Christina Weng and Nathan Steinle discuss individualized management options for a community-based nAMD patient case, offering insights into best practices for durable anti-VEGF therapeutic options through analysis of the latest clinical evidence and patient characteristics and preferences.

Using a quiz-based format, this accredited CME activity offers a brief, interactive microlearning experience centered around a clinical case scenario, enabling clinicians to quickly test their understanding of weight-related eligibility criteria for kidney transplantation, compare their answers with peer responses, and gain expert insights through video commentary. Faculty explore how obesity affects transplant candidacy, evaluation strategies, and potential interventions to optimize patients for transplant, as well as provide key takeaways to support informed, patient-centered clinical decisions.

Upon completion of this activity, learners will be able to:

• Implement routine OSA screening for patients with obesity and other OSA risk factors.
• Identify tools that can aid in screening patients for OSA.
• Initiate diagnostic workups for patients with suspected OSA.
• Evaluate results from OSA diagnostic studies.
• Implement multidisciplinary approaches to formulate tailored management strategies for OSA that account for patient preferences and new therapeutic options.

This complimentary CME course offers a focused review of DKA and HHS, emphasizing critical management strategies, including intravenous fluid administration and insulin therapy. Designed for healthcare professionals, the course aims to enhance clinical decision-making skills in acute diabetic emergencies.

Recent advancements in refractive surgery techniques and technologies continue to evolve, offering expanded options for managing patients with refractive errors. Lens-based refractive surgery presents an alternative to traditional laser-based approaches, providing a broader range of correctable refractive errors and enabling personalized treatment plans tailored to each patient’s unique needs. In this CE monograph, experts will explore the current role of lens-based refractive surgery for myopia correction, compare it with traditional laser-based refractive procedures, and share valuable clinical insights on selecting the most suitable patients for lens-based versus laser-based refractive surgery in the context of myopia treatment.

Neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and diabetic retinopathy (DR) are prevalent retinal conditions that significantly impact vision worldwide. High treatment burden involving frequent intravitreal injections poses a significant barrier to treatment adherence and improved patient outcomes. Advances in anti-vascular endothelial growth factor (VEGF) treatment strategies aim to extend dosing intervals while maintaining efficacy, improving treatment adherence and patient satisfaction. This program equips comprehensive ophthalmologists with the latest data on current and emerging therapies for nAMD, DME, and DR that promise to reduce treatment burden. Expert faculty discuss real-world evidence and personalized approaches to optimize fluid control, reduce injection frequency, and enhance visual and anatomical outcomes.

Second-generation anti-vascular endothelial growth factor (VEGF) therapies provide patients with diabetic macular edema (DME) and diabetic retinopathy (DR) the opportunity for improved visual and anatomical outcomes with less-frequent dosing. However, managing patients with DME/DR can be complex, requiring collaborative-care approaches to offer personalized treatment options and address care disparities. In this CE activity, Drs. Christina Weng and Dennis Marcus discuss collaborative care approaches and individualized management options for a community-based DME patient case, offering clinical insights for the optimal incorporation of durable anti-VEGF therapeutic options into management protocols through analysis of the latest clinical evidence and patient characteristics and preferences.

In this 1-hour (chapter-based) presentation, join a primary care practitioner and an obesity specialist as they navigate real-world conversations about weight management. Explore effective pharmacologic options and gain confidence in initiating weight loss discussions.

Includes six online, self-learning activities: 

• Getting to what’s behind the itch: exploring the root causes and treatment strategies for atopic dermatitis – (1 hr CE) ACCME ACPE MOC 
• Tackling a sore subject: best practices in the identification and management of psoriatic arthritis (PsA) – (1 hr CE) ACCME ACPE MOC
• A critical appraisal of present and emerging management approaches to moderate to severe plaque psoriasis in adults: going beyond skin-deep –  (1.25 hr CE) ACCME ACPE MOC
• Spotlight on actinic keratosis: updates in practice and treatment optimization – (1 hr CE) ACCME ACPE MOC
• Recognition and management of epidermolysis bullosa: what the clinician needs to know – (1 hr CE) ACCME ACPE MOC
• Present and novel approaches in the medical management of generalized pustular psoriasis: balancing out the therapeutic landscape  (1 hr CE) ACCME ACPE MOC

Target Audience: Physicians focusing on Allergy, Dermatology, Rheumatology

In this brief 15-minute activity, you will:

– Follow the case of a patient who presents with foot drop and no other medical conditions
– Choose optimal management approaches by answering nongraded questions within the activity (answers are collected for informational purposes only and used to assess the effectiveness of this educational activity)
– See how your answers compare with those of your peers
– View video clips providing expert insights

In this online, self-learning activity:

Pulmonary hypertension (PH) comprises five etiologic groups; Group I, pulmonary arterial hypertension (PAH), is a precapillary entity defined hemodynamically by right‑heart catheterization: mean pulmonary artery pressure >20 mm Hg, pulmonary artery wedge pressure ≤15 mm Hg, and pulmonary vascular resistance ≥3 Wood units. PAH is uncommon but consequential; estimates place U.S. prevalence near 10.6 per million, with contemporary data showing rarity yet meaningful population burden. Sex differences are notable—women predominate, while men may experience more severe trajectories—underscoring the need for sex‑aware assessment. Multinational reviews suggest incidence and prevalence remain non‑trivial, with enduring morbidity and mortality despite therapeutic gains.

Target Audience: Neurologists

In this 15-minute activity, meet 2 patients with arm pain, one of whom also presents with neck pain. How would you manage these patients? This accredited activity uses an interactive, quiz-driven microlearning format to explore clinical case scenarios with targeted questions, allowing clinicians to quickly assess their knowledge. Clinicians can compare their responses with those of their peers and receive expert guidance through video commentary.

In this CME activity, discover the latest information on investigational factor XI/XIa inhibitors, including results from completed clinical trials and news about ongoing clinical trials, to explore their potential role in managing stroke risk in patients with atrial fibrillation (AF).

Target Audience: Physicians focusing on Allergy or Dermatology

In this #CME #MedX, get the latest guidance on managing hypertrophic cardiomyopathy (HCM), including confirming an obstructive HCM (oHCM) diagnosis, integrating recent clinical information on cardiac myosin inhibitor treatments, and addressing patients’ concerns and questions about living with HCM.

Target Audience: Healthcare professionals specializing in colon and rectal surgery, family medicine, internal medicine, gastroenterology, oncology, pain management, palliative care, primary care, proctology, and other clinicians who treat patients suffering from gastrointestinal disorders.